Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Assessment of hemostatic changes after initiation of continuous venovenous hemodialysis.

Wand S, Schneider S, Meybohm P, Zacharowski K, Weber CF.

Clin Lab. 2015;61(3-4):379-87.

PMID:
25975006
2.

[Impact of acute normovolemic hemodilution on primary hemostasis].

Reyher C, Bingold TM, Menzel S, Zacharowski K, Müller M, Pape A, Weber CF.

Anaesthesist. 2014 Jun;63(6):496-502. doi: 10.1007/s00101-014-2325-8. Epub 2014 May 14. Review. German.

PMID:
24820356
3.

Aggregometric assessment of clonidine's impact on the efficacy of dual platelet inhibition.

Adam EH, Baro D, Schmidt P, Mutlak H, Zacharowski K, Hanke AA, Weber CF.

Clin Lab. 2014;60(9):1533-9.

PMID:
25291950
4.

Multiple electrode aggregometry for the assessment of acquired platelet dysfunctions during extracorporeal circulation.

Mutlak H, Reyher C, Meybohm P, Papadopoulos N, Hanke AA, Zacharowski K, Weber CF.

Thorac Cardiovasc Surg. 2015 Feb;63(1):21-7. doi: 10.1055/s-0034-1383817. Epub 2014 Aug 1.

PMID:
25083831
5.
6.

A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery.

Weber CF, Dietrich W, Spannagl M, Hofstetter C, Jámbor C.

Anesth Analg. 2010 Mar 1;110(3):702-7. doi: 10.1213/ANE.0b013e3181c92a5c. Epub 2009 Dec 30.

PMID:
20042444
7.

Influence of temperature on thromboelastometry and platelet aggregation in cardiac arrest patients undergoing targeted temperature management.

Jeppesen AN, Kirkegaard H, Ilkjær S, Hvas AM.

Crit Care. 2016 Apr 30;20(1):118. doi: 10.1186/s13054-016-1302-9.

8.

Assessment of the Hemostatic Parameters and Platelet Function on Thromboelastometry and Impedance Aggregometry in Hemodialysis Patients Qualified for Kidney Transplantation: Preliminary Report.

Pluta J, Nicińska B, Grzeszczyk M, Kołacz M, Jureczko L, Kwiatkowski A, Durlik M, Trzebicki J.

Transplant Proc. 2016 Jun;48(5):1431-4. doi: 10.1016/j.transproceed.2016.02.057.

PMID:
27496422
9.

Response to dual antiplatelet therapy in patients with peripheral artery occlusive disease suffering from critical limb ischemia.

Wand S, Baro D, Baecker C, Meybohm P, Schmitz-Rixen T, Zacharowski K, Mutlak H, Weber CF.

Clin Lab. 2014;60(10):1601-7.

PMID:
25651704
10.

Who may not benefit from continuous renal replacement therapy in acute kidney injury?

Kawarazaki H, Uchino S, Tokuhira N, Ohnuma T, Namba Y, Katayama S, Toki N, Takeda K, Yasuda H, Izawa J, Uji M, Nagata I; JSEPTIC (Japanese Society for Physicians Trainees in Intensive Care) Clinical Trial Group.

Hemodial Int. 2013 Oct;17(4):624-32. doi: 10.1111/hdi.12053. Epub 2013 May 7.

PMID:
23651363
11.

Early initiation of continuous renal replacement therapy improves survival of elderly patients with acute kidney injury: a multicenter prospective cohort study.

Park JY, An JN, Jhee JH, Kim DK, Oh HJ, Kim S, Joo KW, Oh YK, Lim CS, Kang SW, Kim YS, Park JT, Lee JP.

Crit Care. 2016 Aug 16;20(1):260. doi: 10.1186/s13054-016-1437-8.

12.

Outcome of continuous renal replacement therapy in critically ill children: a retrospective cohort study.

Al-Ayed T, Rahman NU, Alturki A, Aljofan F.

Ann Saudi Med. 2018 Jul-Aug;38(4):260-268. doi: 10.5144/0256-4947.2018.260.

13.

The effect of regional citrate anti-coagulation on the coagulation system in critically ill patients receiving continuous renal replacement therapy for acute kidney injury - an observational cohort study.

Fisher R, Lei K, Mitchell MJ, Moore GW, Dickie H, Tovey L, Crichton S, Ostermann M.

BMC Nephrol. 2017 Oct 2;18(1):304. doi: 10.1186/s12882-017-0718-z.

14.

[Influence of time of initiation of continuous renal replacement therapy on prognosis of critically ill patients with acute kidney injury].

Hu ZJ, Liu LX, Zhao CC.

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2013 Jul;25(7):415-9. doi: 10.3760/cma.j.issn.2095-4352.2013.07.012. Chinese.

15.

Association of Thrombocytopenia and Mortality in Critically Ill Patients on Continuous Renal Replacement Therapy.

Guru PK, Singh TD, Akhoundi A, Kashani KB.

Nephron. 2016;133(3):175-82. doi: 10.1159/000447543. Epub 2016 Jul 6.

PMID:
27380175
16.

Estimating the impact of renal replacement therapy choice on outcome in severe acute renal failure.

Swartz RD, Bustami RT, Daley JM, Gillespie BW, Port FK.

Clin Nephrol. 2005 May;63(5):335-45.

PMID:
15909592
17.

Does early initiation of continuous renal replacement therapy affect outcome: experience in a tertiary care center.

Vats HS, Dart RA, Okon TR, Liang H, Paganini EP.

Ren Fail. 2011;33(7):698-706. doi: 10.3109/0886022X.2011.589945.

PMID:
21787161
18.

Mean platelet volume is a prognostic factor in patients with acute kidney injury requiring continuous renal replacement therapy.

Han JS, Park KS, Lee MJ, Kim CH, Koo HM, Doh FM, Kim EJ, Han JH, Park JT, Han SH, Yoo TH, Kang SW, Oh HJ.

J Crit Care. 2014 Dec;29(6):1016-21. doi: 10.1016/j.jcrc.2014.07.022. Epub 2014 Jul 24.

PMID:
25138689
19.

Discrepant fibrinolytic response in plasma and whole blood during experimental endotoxemia in healthy volunteers.

Ostrowski SR, Berg RM, Windeløv NA, Meyer MA, Plovsing RR, Møller K, Johansson PI.

PLoS One. 2013;8(3):e59368. doi: 10.1371/journal.pone.0059368. Epub 2013 Mar 15.

20.

Intensity of continuous renal replacement therapy for acute kidney injury.

Fayad AI, Buamscha DG, Ciapponi A.

Cochrane Database Syst Rev. 2016 Oct 4;10:CD010613. Review.

Supplemental Content

Support Center